Carlson Capital L.P. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 8,600 shares of the exchange traded fund’s stock, valued at approximately $775,000. SPDR S&P Biotech ETF comprises 0.5% of Carlson Capital L.P.’s investment portfolio, making the stock its 16th largest position.
Other hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Avior Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC increased its position in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $43,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI stock opened at $88.25 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market cap of $5.82 billion, a PE ratio of 11.47 and a beta of 0.93. The business’s fifty day moving average is $91.11 and its 200-day moving average is $95.87.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Choose Top Rated Stocks
- Buffett’s on the Sidelines – Should You Follow?
- Market Cap Calculator: How to Calculate Market Cap
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Most active stocks: Dollar volume vs share volume
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.